How To Easily Set Up Own Pipetting Protocols on Electronic PipettesVideo
Learn how easy it can be to program an electronic single or multichannel micropipette.
How To Achieve Compliance in QC of Nitrogen-containing CompoundsVideo
Learn how to implement a fast and fully compliant SOP for testing of pharmaceuticals in your laboratory with our free webinar.
ADME 101 Drug Metabolism Webinar: Reaction Phenotyping StudiesVideo
It is important to identify the enzymes that significantly contribute to the metabolism of a drug candidate and to evaluate the potential of a drug candidate to be a victim or perpetrator. Knowing how a drug candidate is eliminated by the human body is important in understanding the potential for drug-drug interactions.
Making of Neoma MC-ICP-MSVideo
For scientists whose research requires high-precision isotope ratio data in fields of cosmo- and geochemistry, geochronology and biology, nuclear safeguards, forensics, metalomics, and provenance studies, we have created a new multicollector ICP-MS. Designed and developed in Bremen, building on the strengths of our multi-collector platform with field-proven technologies such as RPQ, 10^13 ohm Amplifier Technology and Jet Interface.
Today our host Jen Fournier is in the lab with the dirtiest, grimiest samples. She knows if she tries to run them on LC-MS as-is, she’d degrade the column, get low sensitivity … and have to clean the mass spectrometer. Is there a better way to start with clean samples?Watch Now
Automated LC-MSMS methods for Clinical Diagnostics - Realized for therapeutic drug monitoring and viVideo
Tecan and RECIPE have worked together to automate ClinMass® LC-MSMS Complete Kits for the analysis of vitamin D and immunosuppressants on a Freedom EVO® platform, to help meet the demand for high throughput sample preparation for mass spectrometry in clinical labs.Watch Now
Listen as Prof Neil Kelleher, discusses how he believes the Orbitrap Fusion Lumos MS might better characterize unexpected PTMs in Top-Down Proteomics to decode cellular function.Watch Now
The proteome is the most functional component encoded for in the genome. Advances in proteomic technologies allow comprehensive profiling of of signaling pathways, precise expression of therapeutic targets in tissues and cellular subcompartments, and of metabolomic features that determine likelihood of therapeutic response. Moreover the current paradigm shift in cancer therapy with dramatic and durable responses to antibody and checkpoint therapeutics that trascend tumor genomic profiles further emphasize opportunities to identify novel targets and tailor treatment based on their expression patterns. The potential for personalizing cancer treatment based on proteomic and metabolomic profiles will be presented for epithelial type tumors including lung and pancreatic cancer.Watch Now
CRISPR is revolutionizing the life sciences. Genome editing using RNA-programmable nucleases opens up a wealth of experimental options. At the same time, it makes creating new cell and animal models faster, easier and cheaper than in the past. Consequently, researchers in areas as diverse as cell/developmental biology, genetics or clinical research are turning to CRISPR as their method of choice.Watch Now
Learn about how Personalized Medicine is changing how drugs are being developed and how healthcare is being delivered, and how Horizon is helping to enable this change.Watch Now
Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.Watch Now